Fontolizumab

Drug Profile

Fontolizumab

Alternative Names: Anti-IFN-gamma monoclonal antibody - Protein Design Labs; Anti-interferon-gamma monoclonal antibody - Protein Design Labs; HuZAF; SMART anti-gamma interferon antibody

Latest Information Update: 19 Jun 2007

Price : $50

At a glance

  • Originator PDL BioPharma
  • Class Anti-inflammatories; Monoclonal antibodies
  • Mechanism of Action Interferon gamma inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Autoimmune disorders; Crohn's disease; Psoriasis; Rheumatoid arthritis

Most Recent Events

  • 09 Jan 2006 Protein Design Labs is now called PDL BioPharma
  • 31 Dec 2005 Phase-II clinical trials in Rheumatoid arthritis in USA (unspecified route)
  • 22 Dec 2005 Phase-II clinical trials in Crohn's disease in USA (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top